BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Latest News
11:44
Gold prices rise 2.7% amid events in Middle East
Finance11:39
Photo
Fondo Strategico Italiano explores cooperation opportunities in Azerbaijan
Business11:39
Trump says 'most of the candidates' to take over Iran were killed in airstrikes
Other countries11:38
Ministry of Foreign Affairs: No new information regarding Azerbaijani citizens injured in Iran
Domestic policy11:25
IRGC launches airstrikes on government compound in Tel Aviv
Other countries11:21
Azerbaijan may become headquarters of Middle Corridor regional AI hub
ICT11:19
Iranian drones strike Saudi Aramco's largest refinery
Other11:17
Photo
President Ilham Aliyev inspects household waste collection vehicles in Baku
Domestic policy11:10